The Angel® Catheter Pivotal Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

Also called NCT02186223

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 172 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02186223
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02186223. Allocation not applicable; no masking; primary purpose prevention. Start 2015-01 (actual); primary completion 2015-12 (actual). Results posted on 2017-04-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Angel® Catheter Pivotal Clinical Trial
Condition
Venous Thromboembolism
Condition
Trauma
Intervention (Device)
The Angel® Catheter
Lead sponsor
BiO2 Medical (class: industry)
Collaborator
CardioMed Device Consultants, LLC (class: industry)
Collaborator
Intrinsic Imaging, LLC (class: not stated)
Collaborator
Novella Clinical (class: other)

Record details

Record id
cardio:ct-nct02186223
Content hash
0d6130d861d6b36e5b3dea5c8e06bcada76129986424841f0ecbf902072d9a05